Erratum: Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtype (Neuro-Oncology 20:5 DOI: 10.1093/neuonc/nox198)

Jian Teng, Seyedali Hejazi, Lotte Hiddingh, Litia Carvalho, Mark De Gooijer, Hiroaki Wakimoto, Marco Barazas, Marie Tannous, Andrew S. Chi, David P. Noske, Pieter Wesseling, Thomas Wurdinger, Tracy T. Batchelor, Bakhos A. Tannous

Research output: Contribution to journalComment/Letter to the editorAcademic


The authors wish to correct a mistake in Figure 1, Panel A: the label for cell SNZ308, SNZ308r1, and SNZ308r2 should be LNZ308, LNZ308r1, and LNZ308r2, respectively (Volume 20, Issue 5, doi:10.1093/neuonc/nox198).

Original languageEnglish
Pages (from-to)1894
Number of pages1
Issue number12
Publication statusPublished - 1 Dec 2020

Cite this